Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LYZZ Capital is a specialized venture capital firm dedicated to investing in the global healthcare and life sciences sectors. With offices in Shanghai and San Diego, the firm focuses on identifying high-potential companies developing innovative therapeutics, medical devices, and diagnostic tools. LYZZ Capital's investment team consists of industry veterans with deep expertise in drug discovery, clinical development, and regulatory affairs, particularly in the US and Chinese markets. The firm typically targets early to growth-stage opportunities that address significant unmet medical needs in areas such as oncology, metabolic diseases, and infectious diseases. By leveraging its extensive network and cross-border capabilities, LYZZ Capital provides strategic guidance and operational support to help its portfolio companies achieve commercial success.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LYZZ Capital.